Significant Notification of Managerial Transactions
ChemoMetec A/S is focused on providing transparency regarding transactions made by its managerial staff. This important notification, as outlined in Article 19 of EU Regulation No. 596/2014, pertains to recent dealings involving shares in ChemoMetec A/S. The company has diligently processed notifications from those in managerial roles and their closely associated individuals.
Overview of Transactions by Management
The Vice Chair of ChemoMetec’s Board of Directors, Martin Glensbjerg, has conducted transactions that are detailed in the supplementary PDF document provided. The commitment to keeping stakeholders informed reflects ChemoMetec's adherence to regulatory compliance and governance standards.
Details of Transactions
Martin Glensbjerg’s recent transactions illustrate the managerial engagement and confidence in the company's direction. Such movements are vital for investors to assess the sentiment of those leading the organization, offering direct insights into the company's vision and operational strategy.
Company Information
Founded in 1997, ChemoMetec A/S is a prominent developer, manufacturer, and marketer of advanced instruments used for cell counting and other essential measurements. These innovative instruments cater predominantly to the pharmaceutical, biotech, and agricultural sectors across the globe.
Market Presence and Operations
ChemoMetec is listed on Nasdaq OMX Copenhagen, ensuring a significant market presence. The company's commitment to high-quality and reliable instruments enhances its reputation and fosters trust among its stakeholders and clients.
Contact Information
For additional queries and insights, investors and interested parties are encouraged to reach out to:
Kim Nicolajsen, CFO
Telephone (+45) 48 13 10 20
Frequently Asked Questions
What does the notification regarding managerial transactions mean?
The notification serves to inform stakeholders about trading activities performed by individuals in management positions, ensuring transparency.
Who is Martin Glensbjerg?
Martin Glensbjerg is the Vice Chair of the Board of Directors of ChemoMetec A/S and is involved in significant corporate transactions.
How can I access the transaction document?
A detailed PDF document regarding these transactions can be viewed through the official communication channels of ChemoMetec A/S.
What are the main products of ChemoMetec A/S?
ChemoMetec develops instruments primarily for cell counting and various other measurements utilized in pharmaceuticals, biotech, and agriculture.
Where is ChemoMetec A/S listed?
ChemoMetec A/S is listed on Nasdaq OMX Copenhagen, making it a notable player in the market.
